|
advertisement
|
|
|
| Journal Articles Details
|
|
More January, 2004 pharmacogenomics journal articles.- Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
by Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ.
Journal: Toxicol Sci. 11 2003;77(1):19-34
- In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.
by Garrison MW, Schimmels JA, Madaras-Kelly KJ.
Journal: Diagn Microbiol Infect Dis. 47(4):587-93
- Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target.
by De Sousa JM, Lareau SM, Pearson RD, Carvalho EM, Mann BJ, Jeronimo SM.
Journal: Scand J Infect Dis. 35(11-12):826-9
- Protecting communities in pharmacogenetic and pharmacogenomic research.
by Weijer C, Miller PB.
Journal: Pharmacogenomics J. 4(1):9-16
- Cancer trials get set for biomarkers.
by Bouchie A.
Journal: Nat Biotechnol. 22(1):6-7
- Pharmacogenomics, genetic tests, and patent-based incentives.
by Meurer MJ.
Journal: Adv Genet. 50:399-426; discussion 507-10
- The biological magic behind the bullets.
by Stockwell BR.
Journal: Nat Biotechnol. 22(1):37-8
- Management of chronic orofacial pain: today and tomorrow.
by Benoliel R, Sharav Y, Tal M, Eliav E.
Journal: Compend Contin Educ Dent. 24(12):909-20, 922-4, 926-8 passim; quiz 932
- Atovaquone/proguanil resistance in Africa: a case report.
by David KP, Alifrangis M, Salanti A, Vestergaard LS, Rønn A, Bygbjerg IB.
Journal: Scand J Infect Dis. 35(11-12):897-8
- In a hurry to slow life's clock.
by Boyce N.
Journal: US News World Rep. 2003 Dec 29-2004 Jan 5;135(23):74-5
- Pharmacogenetics of paraoxonases: a brief review.
by Draganov DI, La Du BN.
Journal: Naunyn Schmiedebergs Arch Pharmacol. 10 2003;369(1):78-88
- Development of analytical technology in pharmacogenetic research.
by Daly AK.
Journal: Naunyn Schmiedebergs Arch Pharmacol. 09 2003;369(1):133-40
- Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
by Morley KI, Hall WD.
Journal: J Mol Med. 11 2003;82(1):21-30
- Occupational exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHX1, GSTM1, GSTT1 and GSTP1.
by Teixeira JP, Gaspar J, Silva S, Torres J, Silva SN, Azevedo MC, Neves P, Laffon B, Méndez J, Gonçalves C, Mayan O, Farmer PB, Rueff J.
Journal: Toxicology. 195(2-3):231-42
- Cancer pharmacogenetics: polymorphisms, pathways and beyond.
by Ulrich CM, Robien K, McLeod HL.
Journal: Nat Rev Cancer. 3(12):912-20
- Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
by Salavaggione OE, Yang C, Kidd LB, Thomae BA, Pankratz VS, Trepanier LA, Weinshilboum RM.
Journal: J Pharmacol Exp Ther. 11 2003;308(2):617-26
- Clinical relevance of pharmacogenetics.
by Becquemont L.
Journal: Drug Metab Rev. 35(4):277-85
- Cancer pharmacogenetics.
by Marsh S, McLeod HL.
Journal: Br J Cancer. 90(1):8-11
- Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark.
by Jørgensen LB, Christensen MB, Gerstoft J, Mathiesen LR, Obel N, Pedersen C, Nielsen H, Nielsen C.
Journal: Scand J Infect Dis. 35(11-12):800-7
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|